Cardiovascular Risk Reduction in Patients with Diabetes: Implementing clinical trials in practice
Cardiovascular Risk Reduction in Patients with Diabetes: Implementing clinical trials in practice
Language: English
Certificate of Completion
Course Title - Cardiovascular Risk Reduction in Patients with Diabetes: Implementing clinical trials in practice
Course Duration – 1 hr.
Course Type - Online- E-learning Material (ELM)
About This Course:
Insulin resistance, dyslipidaemia, diabetes and hypertension are interrelated conditions that contribute to significant morbidity and mortality worldwide. Insulin resistance often precedes the onset of type 2 diabetes and is closely linked to obesity, physical inactivity, and genetic predisposition. Dyslipidaemia, characterized by abnormal levels of lipids in the blood, is a common metabolic disorder that often coexists with insulin resistance and diabetes, further exacerbating cardiovascular risks. Managing T2DM effectively involves not only controlling blood sugar levels but also addressing comorbid conditions such as dyslipidaemia and hypertension to reduce the overall cardiovascular risk. Sodium-glucose co-transporter-2 inhibitors (SGLT2i) and dipeptidyl peptidase-4 inhibitors (DPP-4i) are two classes of antidiabetic medications that have revolutionized the management of T2DM.
Benefit for Learners:
• Continued professional development and learning
• Better understanding of CV risk reduction in patient with diabetes
• Certification of recognition form the reputed Society/Association/University
Intended Audience:
Consultant Physicians
Learning objectives:
At the end of this activity the participant will be able to understand-
• The link between diabetes, dyslipidaemia and future CV risk
• Benefits of SGLT2i and DPP4i in patients with diabetes
• Treatment guidelines for management of diabetes
Accreditation Statement
This activity is organized by Scholamed Academia (Insignia Communication).
Physician Accreditation Statement
Accreditation is pending.
Educational Grant
This educational activity is independently produced by Scholamed Academia (Insignia Communication).
Method of Participation
Participants should first read the objectives and other introductory CME information and then proceed to the educational activity. If a pre-and post-test is required to receive credit for this activity, participants must complete the post-test and then complete the evaluation.
Certificate:
Participants will gain an Certificate of completion form the reputed Society/Association/University.
Completion Certificate:
Upon completing all modules and assessments, you will receive an e-certificate, recognizing your achievement.
Course Development details
The following faculty stated they have no financial relationships with ineligible companies:
Dr. Shwetal Sanghvi (MBBS, DLO, DORL, FCPS)
Ms Aditi Munghate, Scholamed Academia Planner, stated they have no financial relationships with ineligible companies.
To resolve identified/potential conflicts of interest, the educational content was fully reviewed by a Clinical Content Review Committee which has nothing to disclose. The resulting certified activity was found to provide educational content that is current and evidence-based to protect learners from commercial bias and marketing.
Off-label Statement
This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Further, attendees/participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program.
Disclaimer
The content and views presented in this educational activity are those of the authors and do not necessarily reflect those of Scholamed Academia (Insignia Communications). This material is prepared based upon a review of multiple sources of information, but it is not exhaustive of the subject matter. Therefore, healthcare professionals and other individuals should review and consider other publications and materials on the subject.
Cardiovascular Risk Reduction in Patients with Diabetes: Implementing clinical trials in practice
Language: English
Certificate of Completion
